Shemyakin A - Search Results

1

Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.

Kövamees O, Shemyakin A, Checa A, Wheelock CE, Lundberg JO, Östenson CG, Pernow J. Kövamees O, et al. Among authors: shemyakin a. J Clin Endocrinol Metab. 2016 Nov;101(11):3952-3958. doi: 10.1210/jc.2016-2007. Epub 2016 Jul 11. J Clin Endocrinol Metab. 2016. PMID: 27399350 Clinical Trial.

2

Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels.

Kovamees O, Shemyakin A, Eriksson M, Angelin B, Pernow J. Kovamees O, et al. Among authors: shemyakin a. J Intern Med. 2016 May;279(5):477-84. doi: 10.1111/joim.12461. Epub 2015 Dec 28. J Intern Med. 2016. PMID: 26707366 Free article.

3

New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus.

Pernow J, Shemyakin A, Böhm F. Pernow J, et al. Among authors: shemyakin a. Life Sci. 2012 Oct 15;91(13-14):507-16. doi: 10.1016/j.lfs.2012.03.029. Epub 2012 Mar 28. Life Sci. 2012. PMID: 22483688 Free article. Review.

4

Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.

Shemyakin A, Kövamees O, Rafnsson A, Böhm F, Svenarud P, Settergren M, Jung C, Pernow J. Shemyakin A, et al. Circulation. 2012 Dec 18;126(25):2943-50. doi: 10.1161/CIRCULATIONAHA.112.140335. Epub 2012 Nov 26. Circulation. 2012. PMID: 23183942

5

Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.

Kövamees O, Shemyakin A, Pernow J. Kövamees O, et al. Among authors: shemyakin a. PLoS One. 2014 Jul 29;9(7):e103260. doi: 10.1371/journal.pone.0103260. eCollection 2014. PLoS One. 2014. PMID: 25072937 Free PMC article. Clinical Trial.

6

Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.

Kövamees O, Shemyakin A, Pernow J. Kövamees O, et al. Among authors: shemyakin a. Diab Vasc Dis Res. 2016 Sep;13(5):354-60. doi: 10.1177/1479164116643916. Epub 2016 May 13. Diab Vasc Dis Res. 2016. PMID: 27190086 Free article.

7

Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.

Shemyakin A, Böhm F, Wagner H, Efendic S, Båvenholm P, Pernow J. Shemyakin A, et al. J Cardiovasc Pharmacol. 2006 Mar;47(3):385-90. doi: 10.1097/01.fjc.0000210070.47205.16. J Cardiovasc Pharmacol. 2006. PMID: 16633080

8

Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.

Jung C, Rafnsson A, Shemyakin A, Böhm F, Pernow J. Jung C, et al. Among authors: shemyakin a. Int J Cardiol. 2010 Sep 3;143(3):368-72. doi: 10.1016/j.ijcard.2009.03.075. Epub 2009 Apr 26. Int J Cardiol. 2010. PMID: 19398138

9

Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro.

Shemyakin A, Salehzadeh F, Böhm F, Al-Khalili L, Gonon A, Wagner H, Efendic S, Krook A, Pernow J. Shemyakin A, et al. J Clin Endocrinol Metab. 2010 May;95(5):2359-66. doi: 10.1210/jc.2009-1506. Epub 2010 Mar 5. J Clin Endocrinol Metab. 2010. PMID: 20207830

10

Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.

Gonon AT, Jung C, Katz A, Westerblad H, Shemyakin A, Sjöquist PO, Lundberg JO, Pernow J. Gonon AT, et al. Among authors: shemyakin a. PLoS One. 2012;7(7):e42038. doi: 10.1371/journal.pone.0042038. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters